As of 2025-12-26, the Relative Valuation of Akero Therapeutics Inc (AKRO) is (64.38) USD. This relative valuation is based on P/E multiples. With the latest stock price at 54.65 USD, the upside of Akero Therapeutics Inc based on Relative Valuation is -217.8%.
The range of the Relative Valuation is (46.53) - (74.98) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.0x - 21.1x | 18.0x |
| Forward P/E multiples | 13.1x - 25.6x | 18.2x |
| Fair Price | (46.53) - (74.98) | (64.38) |
| Upside | -185.1% - -237.2% | -217.8% |
| Date | P/E |
| 2025-12-08 | -15.36 |
| 2025-12-05 | -15.34 |
| 2025-12-04 | -15.36 |
| 2025-12-03 | -15.37 |
| 2025-12-02 | -15.32 |
| 2025-12-01 | -15.30 |
| 2025-11-28 | -15.28 |
| 2025-11-26 | -15.28 |
| 2025-11-25 | -15.28 |
| 2025-11-24 | -15.28 |
| 2025-11-21 | -15.27 |
| 2025-11-20 | -15.25 |
| 2025-11-19 | -15.28 |
| 2025-11-18 | -15.27 |
| 2025-11-17 | -15.28 |
| 2025-11-14 | -15.25 |
| 2025-11-13 | -15.24 |
| 2025-11-12 | -15.27 |
| 2025-11-11 | -15.25 |
| 2025-11-10 | -15.22 |
| 2025-11-07 | -15.19 |
| 2025-11-06 | -15.16 |
| 2025-11-05 | -15.19 |
| 2025-11-04 | -15.19 |
| 2025-11-03 | -15.21 |
| 2025-10-31 | -15.24 |
| 2025-10-30 | -15.25 |
| 2025-10-29 | -15.18 |
| 2025-10-28 | -15.18 |
| 2025-10-27 | -15.14 |
| 2025-10-24 | -15.12 |
| 2025-10-23 | -15.10 |
| 2025-10-22 | -15.07 |
| 2025-10-21 | -15.12 |
| 2025-10-20 | -15.16 |
| 2025-10-17 | -15.14 |
| 2025-10-16 | -15.09 |
| 2025-10-15 | -15.07 |
| 2025-10-14 | -15.13 |
| 2025-10-13 | -15.09 |
| 2025-10-10 | -15.15 |
| 2025-10-09 | -15.20 |
| 2025-10-08 | -13.07 |
| 2025-10-07 | -12.93 |
| 2025-10-06 | -12.94 |
| 2025-10-03 | -12.96 |
| 2025-10-02 | -13.05 |
| 2025-10-01 | -13.09 |
| 2025-09-30 | -13.35 |
| 2025-09-29 | -13.39 |